Dr. Dhananjay Chatterjee, MD

Dr. Chatterjee practices at UCLA Medical Plaza in Los Angeles, California.

Dr. Chatterjee's NPI, 1497117782, was assigned on March 24, 2016. Dr. Chatterjee graduated from David Geffen School of Medicine at UCLA in 2016. Dr. Chatterjee's California license number on file is A156184.

Dr. Chatterjee's primary practice is UCLA Medical Plaza, at 5767 W Century Blvd, Los Angeles, CA 90045 in Los Angeles County. The practice phone is (310) 794-1276.

Dr. Chatterjee's primary practice is UCLA Medical Plaza in Los Angeles, California. Dr. Chatterjee is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Chatterjee to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chatterjee practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Chatterjee's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Chatterjee is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Chatterjee has a license on file in California.

Dmand AI lists aneurysm, angioplasty, aortic atherosclerois, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, chronic hypertension and coronary artery disease among the conditions Dr. Chatterjee treats.

CMS data shows 3,866 Medicare services from Dr. Chatterjee across 32 procedure codes in 2024, for 824 Medicare patients. Medicare paid $369,665 for them.

CMS counts 824 Medicare patients who saw Dr. Chatterjee in 2024. The largest group is 65 to 74, with 395 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chatterjee's median patient age at 69, with 42% women.

In 2024, Dr. Chatterjee wrote 2,563 Medicare Part D claims for 583 patients. 85% of them were for generic drugs. CMS names the drug for 2,304 of them, across 35 drugs with 11 or more claims each, at $356,933 in total drug cost. In 2023, CMS named 225 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Chatterjee for performance year 2024, reported as part of a group. Dr. Chatterjee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chatterjee as offering telehealth. CMS counts 54 procedures of coronary angioplasty and stenting by Dr. Chatterjee, more than 86% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Chatterjee, published from 2017 to 2025. Dr. Chatterjee's most frequent co-authors are Evan Oliver Baird, MD, Matthew J. Budoff, MD and Mohamad Bydon, MD.

CMS Open Payments shows 307 general payments to Dr. Chatterjee from 17 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 48% of the total. ShockWave Medical, Inc paid the most, $58,198.

Dr. Chatterjee graduated from David Geffen School of Medicine at UCLA in 2016.

Dr. Chatterjee is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Highmark. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.